Adjuvant Therapy With Nivolumab Versus Placebo in Patients With Resected Stage IIB/C Melanoma (Checkmate 76K)

被引：0

作者：

Gastman, Brian ^{[1
]}

Long, Georgina V. ^{[2
]}

Kirkwood, John M. ^{[3
]}

Hoeller, Christoph ^{[4
,5
]}

Weber, Jeffrey ^{[6
]}

Grob, Jean-Jacques ^{[7
]}

Mohr, Peter ^{[8
]}

Grabbe, Stephan ^{[9
]}

Dutriaux, Caroline ^{[10
]}

Chiarion-Sileni, Vanna ^{[11
]}

Mackiewicz, Jacek ^{[12
]}

Rutkowski, Piotr ^{[13
]}

Arenberger, Petr ^{[14
,15
]}

Quereux, Gaelle ^{[16
]}

Meniawy, Tarek ^{[17
]}

Ascierto, Paolo A. ^{[18
]}

van Akkooi, Alexander ^{[19
,20
]}

Durani, Piyush ^{[21
]}

Campigotto, Federico ^{[21
]}

Del Vecchio, Michele ^{[22
]}

机构：

[1] Cleveland Clin Fdn, Melanoma & High Risk Skin Canc Program, Cleveland, OH USA

[2] Univ Sydney, Melanoma Inst Australia, Royal North Shore & Mater Hosp, Sydney, NSW, Australia

[3] UPMC Hillman Canc Ctr, Melanoma & Skin Canc P, Med Dermatol, Pittsburgh, PA USA

[4] Med Univ Wien, Dermatol, Vienna, Austria

[5] Med Univ Wien, Skin Canc Ctr, Vienna, Austria

[6] NYU Langone Med Ctr, Perlmutter Canc Ctr, New York, NY USA

[7] Hop La Timone, Dermatol, Marseille, France

[8] Elbe Klinikum Buxtehude, Buxtehude, Germany

[9] Univ Mainz Med Ctr, Dermatol, Mainz, Germany

[10] Hop St Andre, Bordeaux, France

[11] IRCCS, Ist Oncol Veneto, Melanoma & Esophageal Oncol Unit, San Giovanni Rotondo, Italy

[12] Poznan Univ Med Sci, Poznan, Poland

[13] Maria Sklodowska Curie Natl Res Inst Oncol, Surg Oncol, Warsaw, Poland

[14] Charles Univ Prague, Fac Med 3, Dept Dermatovenereol, Prague, Czech Republic

[15] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic

[16] Nantes Univ Hosp, Nantes, France

[17] 15Sir Charles Gairdner Hosp, City Beach, WA USA

[18] Ist Nazl Tumori IRCCS Fdn G Pascale, Unit Melanoma Canc Immunotherapy & Innovat Therap, Canc Immunotherapy & Dev Therapeut Unit, Naples, Italy

[19] Univ Sydney, Melanoma Inst Australia, Fac Med & Hlth, Sydney, NSW, Australia

[20] Royal Prince Alfred Hosp, Sydney, NSW, Australia

[21] Bristol Myers Squibb, Global Oncol Clin Dev, New York, NY USA

[22] Fdn IRCCS Ist Nazl Tumori, Unit Melanoma Med Oncol, Milan, Italy

来源：

ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S35 / S36

页数：2

共 50 条

[1] Adjuvant nivolumab (NIVO) v placebo (PBO) in stage IIB/C melanoma: Update from CheckMate 76K
Kirkwood, J. M.
Weber, J.
Hoeller, C.
Grob, J.
Mohr, P.
Grabbe, S.
Dutriax, C.
Chiarion-Sileni, V.
Mackiewicz, J.
Rutkowski, P.
Arenberger, P.
Meniawy, T.
Dalle, S.
Mandala, M.
van Akkooi, A.
Nassar, A.
Campigotto, F.
Long, G. V.
Del Vecchio, M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S48 - S48
[2] Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
Kirkwood, John
Del Vecchio, Michele
Weber, Jeffrey
Hoeller, Christoph
Grob, Jean-Jacques
Mohr, Peter
Loquai, Carmen
Dutriaux, Caroline
Chiarion-Sileni, Vanna
Mackiewicz, Jacek
Rutkowski, Piotr
Arenberger, Petr
Quereux, Gaelle
Meniawy, Tarek M.
Ascierto, Paolo A.
Menzies, Alexander M.
Durani, Piyush
Lobo, Maurice
Campigotto, Federico
Gastman, Brian
Long, Georgina V.
NATURE MEDICINE, 2023, 29 (11) : 2835 - 2843
[3] Adjuvant nivolumab v placebo in stage IIB/C melanoma: 3-year results from CheckMate 76K
Long, G. V.
Del Vecchio, M.
Hoeller, C.
Weber, J. S.
Grob, J. J.
Mohr, P.
Grabbe, S.
Dutriaux, C.
Sileni, V. Chiarion
Mackiewicz, J.
Rutkowski, P.
Arenberger, P.
Quereux, G.
Meniawy, T.
Ascierto, P. A.
Taube, J.
Nassar, A.
Wang, W.
Kirkwood, J. M.
ANNALS OF ONCOLOGY, 2024, 35 : S713 - S714
[4] Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
John M. Kirkwood
Michele Del Vecchio
Jeffrey Weber
Christoph Hoeller
Jean-Jacques Grob
Peter Mohr
Carmen Loquai
Caroline Dutriaux
Vanna Chiarion-Sileni
Jacek Mackiewicz
Piotr Rutkowski
Petr Arenberger
Gaelle Quereux
Tarek M. Meniawy
Paolo A. Ascierto
Alexander M. Menzies
Piyush Durani
Maurice Lobo
Federico Campigotto
Brian Gastman
Georgina V. Long
Nature Medicine, 2023, 29 : 2835 - 2843
[5] Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
John M. Kirkwood
Michele Del Vecchio
Jeffrey Weber
Christoph Hoeller
Jean-Jacques Grob
Peter Mohr
Carmen Loquai
Caroline Dutriaux
Vanna Chiarion-Sileni
Jacek Mackiewicz
Piotr Rutkowski
Petr Arenberger
Gaelle Quereux
Tarek M. Meniawy
Paolo A. Ascierto
Alexander M. Menzies
Piyush Durani
Maurice Lobo
Federico Campigotto
Brian Gastman
Georgina V. Long
Nature Medicine, 2024, 30 : 607 - 607
[6] Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (vol 29, pg 2835, 2023)
Kirkwood, John M.
Del Vecchio, Michele
Weber, Jeffrey
Hoeller, Christoph
Grob, Jean-Jacques
Mohr, Peter
Loquai, Carmen
Dutriaux, Caroline
Chiarion-Sileni, Vanna
Mackiewicz, Jacek
Rutkowski, Piotr
Arenberger, Petr
Quereux, Gaelle
Meniawy, Tarek M.
Ascierto, Paolo A.
Menzies, Alexander M.
Durani, Piyush
Lobo, Maurice
Campigotto, Federico
Gastman, Brian
Long, Georgina V.
NATURE MEDICINE, 2024, 30 (03) : 906 - 906
[7] Association of biomarkers (BMs) with efficacy of adjuvant nivolumab (NIVO) vs placebo (PBO) in patients with resected stage IIB/C melanoma (CA209-76K).
Long, Georgina V.
Kirkwood, John M. M.
Hoeller, Christoph
Grob, Jean-Jacques
Weber, Jeffrey S.
Taube, Janis M.
Mohr, Peter
Van Akkooi, Alexander Christopher Jonathan
Loquai, Carmen
Dutriaux, Caroline
Chiarion-Sileni, Vanna
Tenney, Daniel J.
Dolfi, Sonia
Tang, Hao
Ritchings, Corey
Lobo, Maurice
Campigotto, Federico
Wang, Wenjia
Gastman, Brian
Del Vecchio, Michele
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[8] Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (16 OCT, 10.1038/s41591-023-02583-2, 2023 )
Kirkwood, John M.
Del Vecchio, Michele
Weber, Jeffrey
Hoeller, Christoph
Grob, Jean-Jacques
Mohr, Peter
Loquai, Carmen
Dutriaux, Caroline
Chiarion-Sileni, Vanna
Mackiewicz, Jacek
Rutkowski, Piotr
Arenberger, Petr
Quereux, Gaelle
Meniawy, Tarek M.
Ascierto, Paolo A.
Menzies, Alexander M.
Durani, Piyush
Lobo, Maurice
Campigotto, Federico
Gastman, Brian
Long, Georgina V.
NATURE MEDICINE, 2023, 30 (2) : 607 - 607
[9] Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
Weber, Jeffrey S.
Schadendorf, Dirk
Del Vecchio, Michele
Larkin, James
Atkinson, Victoria
Schenker, Michael
Pigozzo, Jacopo
Gogas, Helen
Dalle, Stephane
Meyer, Nicolas
Ascierto, Paolo A.
Sandhu, Shahneen
Eigentler, Thomas
Gutzmer, Ralf
Hassel, Jessica C.
Robert, Caroline
Carlino, Matteo S.
Di Giacomo, Anna Maria
Butler, Marcus O.
Munoz-Couselo, Eva
Brown, Michael P.
Rutkowski, Piotr
Haydon, Andrew
Grob, Jean-Jacques
Schachter, Jacob
Queirolo, Paola
de la Cruz-Merino, Luis
Haydon, Andrew
Grob, Jean-Jacques
Schachter, Jacob
Queirolo, Paola
De La Cruz-Merino, Luis
van der Westhuizen, Andre
Menzies, Alexander M.
Re, Sandra
Bas, Tuba
de Pril, Veerle
Braverman, Julia
Tenney, Daniel J.
Tang, Hao
Long, Georgina, V
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 517 - +
[10] Indirect treatment comparison of nivolumab versus placebo as an adjuvant therapy for resected melanoma
Shoushtari, Alexander Noor
Freeman, Morganna Louise
Betts, Keith A.
Gupte-Singh, Komal
Du, Ella X.
Ritchings, Corey
Rao, Sumati
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

← 1 2 3 4 5 →